Adhesive Capsulitis
Conditions
Brief summary
The purpose of this study is to compare the efficacy of intra-articular steroid injection, sodium hyaluronate injection, a combination of the two, and placebo in the treatment of adhesive capsulitis of the shoulder.
Interventions
* Total volume of injection drugs: 8ml * isotonic saline 4ml + telebrix(contrast media) 4ml * The number of injections : only once during the study period * Injection site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
* Total volume of injection drugs: 8ml * triamcinolone(40mg)1ml + isotonic saline 3ml + telebrix(contrast media)4ml * The number of injections : only once during the study period * Injection Site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
* Total volume of injection drugs: 8ml * sodium hyaluronate 2ml + isotonic saline 2ml + telebrix(contrast media)4ml * The number of injections : only once during the study period * Injection Site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
* Total volume of injection drugs: 8ml * triamcinolone(40mg)1ml + sodium hyaluronate 2ml + isotonic saline 1ml + telebrix(contrast media)4ml * The number of injections : only once during the study period * Injection Site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
Sponsors
Study design
Eligibility
Inclusion criteria
* clinical diagnosis : Adhesive Capsulitis of the Shoulder * defining of adhesive capsulitis * the presence of shoulder pain * limitation of both active and passive movements of the glenohumeral joint of ≥25% in at list 2 directions(abduction,flexion,external rotation,internal rotation), as compared with the contralateral shoulder * duration : symptomatic for \< 1 year
Exclusion criteria
* bilateral symptoms * uncontrolled diabetes mellitus * overt hypothyroidism or hyperthyroidism * previous shoulder surgery * previous glenohumeral joint injection within recent 6months * trauma to the shoulder the last six months that required hospital care * neurological symptoms * allergy to injection material * secondary adhesive capsulitis * systemic inflammatory ds including rheumatoid arthritis * degenerative arthritis of shoulder joint * infectious arthritis of shoulder joint * dislocation of shoulder joint * blood coagulation disease * rotator cuff tear * serious mental illness * pregnancy * fracture in shoulder lesion * CVA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SPADI Score (Shoulder Pain and Disability Index) | Postinjection 1month |
Countries
South Korea